Brief: Cumberland Pharmaceuticals Posts Q2 EPS Of $0.08
10/08/2021 22:47
Aug 10 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS & COMPANY UPDATE
* Q2 EARNINGS PER SHARE $0.08
* Q2 REVENUE $9.1 MILLION VERSUS $9.6 MILLION
Source text for Eikon: ID:nPnbqyhdLa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM